It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication.
Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged.
It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School.
“There are so many other barriers to prescribing that we have to address,” said Chua.
The findings were published Wednesday in the New England Journal of Medicine.
LIZ JONES: How the past few days have shown us the depth of Kate and Charles's special relationship
Bird flu is spreading to more farm animals. Are milk and eggs safe?
Does the U.S. See Pacific Island Countries As True Partners?
Nanjing Railway Station experienced a small peak of passenger flow in weekend
Malaria is still killing people in Kenya, but a vaccine and local drug production may help
Uninsured driver, 33, who hit district judge with his car seconds before the father
Regional Canine Training Center of World Customs Organization opens in Hong Kong
GT Voice: US Treasury yield signals economy in ‘vicious cycle’
Bob Cole, the voice of hockey in Canada for a half
Kylie Minogue plays peekaboo in sparkling black dress as she's honored at the TIME 100 Gala in NYC
News Analysis: Türkiye's economic woes far from over amid tumbling currency, looming debt